BioMarin
USA · Pharma & Healthcare
LeaveRussia detail: Continue Operations
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies.
Decision trail
Decision date 15/01/2023 · Reference ↗
“Coping with the consequences of pandemic, followed by the war in Ukraine and our exit from Russia, our organisation has focused on improving commercial and operational excellence." Revenue increased in 2024 vs 2023 by more than +30%.
Local stats (LeaveRussia)
Assets(RF), mln.USD
1
Capital(RF), mln.USD
1
Glob.Revenue, mln.USD
2419
Revenue(RF), mln.USD
7
Staff(RF), 2021
56
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional